Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

[Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].

Yang M, Liu Y, Zhou G, Guo X, Zou S, Liu S, Jiang L, Liu Y, Zhu L, Guo C, Zhao J.

Zhonghua Gan Zang Bing Za Zhi. 2016 Feb;24(2):96-101. doi: 10.3760/cma.j.issn.1007-3418.2016.02.005. Chinese.

PMID:
26983475
2.

Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.

Kumagai K, Tabu K, Sasaki F, Takami Y, Morinaga Y, Mawatari S, Hashimoto S, Tanoue S, Kanmura S, Tamai T, Moriuchi A, Uto H, Tsubouchi H, Ido A.

PLoS One. 2015 Nov 23;10(11):e0143413. doi: 10.1371/journal.pone.0143413. eCollection 2015.

3.

Anti-fibrotic effect of plumbagin on CCl₄-lesioned rats.

Wei Y, Huang M, Liu X, Yuan Z, Peng Y, Huang Z, Duan X, Zhao T.

Cell Physiol Biochem. 2015;35(4):1599-608. doi: 10.1159/000373974. Epub 2015 Mar 18.

PMID:
25824458
4.

An algorithm that predicts the viability and the yield of human hepatocytes isolated from remnant liver pieces obtained from liver resections.

Lee SM, Schelcher C, Laubender RP, Fröse N, Thasler RM, Schiergens TS, Mansmann U, Thasler WE.

PLoS One. 2014 Oct 14;9(10):e107567. doi: 10.1371/journal.pone.0107567. eCollection 2014.

5.

A nonhuman primate model of human radiation-induced venocclusive liver disease and hepatocyte injury.

Yannam GR, Han B, Setoyama K, Yamamoto T, Ito R, Brooks JM, Guzman-Lepe J, Galambos C, Fong JV, Deutsch M, Quader MA, Yamanouchi K, Kabarriti R, Mehta K, Soto-Gutierrez A, Roy-Chowdhury J, Locker J, Abe M, Enke CA, Baranowska-Kortylewicz J, Solberg TD, Guha C, Fox IJ.

Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):404-11. doi: 10.1016/j.ijrobp.2013.10.037. Epub 2013 Dec 5.

6.

Effects of lifestyle changes including specific dietary intervention and physical activity in the management of patients with chronic hepatitis C--a randomized trial.

Rusu E, Jinga M, Enache G, Rusu F, Dragomir AD, Ancuta I, Draguţ R, Parpala C, Nan R, Sima I, Ateia S, Stoica V, Cheţa DM, Radulian G.

Nutr J. 2013 Aug 14;12:119. doi: 10.1186/1475-2891-12-119.

7.

Recombinant bovine pancreatic trypsin inhibitor protects the liver from carbon tetrachloride-induced chronic injury in rats.

Dong W, Lv B, Wei F, Yang L.

Pharm Biol. 2013 Oct;51(10):1298-303. doi: 10.3109/13880209.2013.789537. Epub 2013 Jul 16.

PMID:
23855331
8.

Glycyrrhizic acid attenuates CCl₄-induced hepatocyte apoptosis in rats via a p53-mediated pathway.

Guo XL, Liang B, Wang XW, Fan FG, Jin J, Lan R, Yang JH, Wang XC, Jin L, Cao Q.

World J Gastroenterol. 2013 Jun 28;19(24):3781-91. doi: 10.3748/wjg.v19.i24.3781.

9.

Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.

Okada Y, Yamaguchi K, Nakajima T, Nishikawa T, Jo M, Mitsumoto Y, Kimura H, Nishimura T, Tochiki N, Yasui K, Mitsuyoshi H, Minami M, Kagawa K, Okanoue T, Itoh Y.

Liver Int. 2013 Feb;33(2):301-11. doi: 10.1111/liv.12033.

PMID:
23295058
10.

Green tea extract supplementation ameliorates CCl4-induced hepatic oxidative stress, fibrosis, and acute-phase protein expression in rat.

Hung GD, Li PC, Lee HS, Chang HM, Chien CT, Lee KL.

J Formos Med Assoc. 2012 Oct;111(10):550-9. doi: 10.1016/j.jfma.2011.06.026. Epub 2012 Mar 9.

11.

Inhibitory effects of salvianolic acid B on CCl(4)-induced hepatic fibrosis through regulating NF-κB/IκBα signaling.

Wang R, Yu XY, Guo ZY, Wang YJ, Wu Y, Yuan YF.

J Ethnopharmacol. 2012 Dec 18;144(3):592-8. doi: 10.1016/j.jep.2012.09.048. Epub 2012 Oct 3.

PMID:
23041223
12.

Effect and mechanism of methyl helicterate isolated from Helicteres angustifolia (Sterculiaceae) on hepatic fibrosis induced by carbon tetrachloride in rats.

Huang Q, Li Y, Zhang S, Huang R, Zheng L, Wei L, He M, Liao M, Li L, Zhuo L, Lin X.

J Ethnopharmacol. 2012 Oct 11;143(3):889-95. doi: 10.1016/j.jep.2012.08.018. Epub 2012 Aug 28.

PMID:
22967666
13.

The effectiveness of liraglutide in nonalcoholic fatty liver disease patients with type 2 diabetes mellitus compared to sitagliptin and pioglitazone.

Ohki T, Isogawa A, Iwamoto M, Ohsugi M, Yoshida H, Toda N, Tagawa K, Omata M, Koike K.

ScientificWorldJournal. 2012;2012:496453. doi: 10.1100/2012/496453. Epub 2012 Aug 13.

14.

Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr.

Kitamori K, Naito H, Tamada H, Kobayashi M, Miyazawa D, Yasui Y, Sonoda K, Tsuchikura S, Yasui N, Ikeda K, Moriya T, Yamori Y, Nakajima T.

Environ Health Prev Med. 2012 May;17(3):173-82. doi: 10.1007/s12199-011-0235-9. Epub 2011 Aug 19.

15.

Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK.

Xu J, Lai KK, Verlinsky A, Lugea A, French SW, Cooper MP, Ji C, Tsukamoto H.

J Hepatol. 2011 Sep;55(3):673-82. doi: 10.1016/j.jhep.2010.12.034. Epub 2011 Jan 21.

16.
17.

Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells.

Liu H, Wei W, Sun WY, Li X.

J Ethnopharmacol. 2009 Apr 21;122(3):502-8. doi: 10.1016/j.jep.2009.01.035. Epub 2009 Feb 5.

PMID:
19429320
18.

A rabbit model of pediatric nonalcoholic steatohepatitis: the role of adiponectin.

Fu JF, Fang YL, Liang L, Wang CL, Hong F, Dong GP.

World J Gastroenterol. 2009 Feb 28;15(8):912-8.

19.

Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.

Nobili V, Manco M, Ciampalini P, Alisi A, Devito R, Bugianesi E, Marcellini M, Marchesini G.

Clin Ther. 2008 Jun;30(6):1168-76. doi: 10.1016/j.clinthera.2008.06.012.

PMID:
18640473
20.

Preventive effect of Qianggan-Rongxian Decoction on rat liver fibrosis.

Li CH, Pan LH, Yang ZW, Li CY, Xu WX.

World J Gastroenterol. 2008 Jun 14;14(22):3569-73.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk